AccessLangeGeneral Ophthalmology
Vaughan, Asbury, Riordan-Eva :
AccessMedicine.com
HomeAboutAccount ServicesBuy BooksSite MapHelpLogoutAccessMedicine HomeAccessMedicine Publications
Full TOC

Related Sites
Forum
View Contents in a new window Separate Window
Printable Version

Search AccessMedicine
 

More Search Options
In AccessLange
In AccessMedicine

Search Drug List
 

Chapter 3: Ophthalmic Therapeutics
REFERENCES
  
• Bito LZ (editor): Ocular effects of prostaglandins and other eicosanoids. Surv Ophthalmol 1997;41(Suppl 2). (Entire issue.)
 
• Camras CB: The United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. Ophthalmology 1996;103:138.  [ PMID 8628544 ]
 
• Davidson SI et al: Ocular toxicity from systemic drug therapy: An overview of clinically important adverse reactions. Med Toxicol 1986;1:217.  [ PMID 3784843 ]
 
• Doft BH et al: Ceftazidime or amikacin: Choice of intravitreal antimicrobials in the treatment of postoperative endophthalmitis. Arch Ophthalmol 1994;112:17.  [ PMID 8285881 ]
 
• Edeki TI, Huabing H. Wood AJJ: Pharmacogenetic explanation for excessive 0x0003b2-blockade following timolol eye drops. JAMA 1995;274:20  [ PMID 7474246 ]
 
• Endophthalmitis Vitrectomy Study Group: Results of the Endophthalmitis Vitrectomy Study: A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995;113:1479.  [ PMID 7487614 ]
 
• Fraunfelder FT: Drug-Induced Ocular Side Effects and Drug Interactions, 4th ed. Lea & Febiger, 1989.
 
• Fraunfelder FT, Roy FH (editors): Current Ocular Therapy, 4th ed. Saunders, 1995.
 
• Grant WM, Schuman JS: Toxicology of the Eye, 4th ed. Thomas, 1993.
 
• Lee VH: Review: New directions in the optimization of ocular drug delivery. J Ocul Pharmacol 1990;6:157.  [ PMID 2203851 ]
 
• Leibowitz HM: Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 1991;112:34S.  [ PMID 1928272 ]
 
• Mauger TF, Craig EL (editors): Havener's Ocular Pharmacology, 6th ed. Mosby, 1994.
 
• Nagasubramanian S et al: Comparisons of apraclonidine and timolol in chronic open-angle glaucoma: A three-month study. Ophthalmology 1993;100:1318.  [ PMID 8371918 ]
 
• Neu HC: Microbiologic aspects of fluoroquinolones. Am J Ophthalmol 1991;112:15S.  [ PMID 1928268 ]
 
• Ophthalmic Drug Facts. Facts & Comparisons. Lippincott-Raven, 1997.
 
• Palmer EA: How safe are ocular drugs in pediatrics? Ophthalmology 1986;93:1038.  [ PMID 3763151 ]
 
• Salminen L: Review: Systemic absorption of topically applied ocular drugs in humans. J Ocul Pharmacol 1990;6:243.  [ PMID 2290070 ]
 
• Wilkerson M et al: Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol 1993;111:1343.  [ PMID 8216014 ]
 
• Zimmerman TJ, Kooner KS, Sharir M (editors): Textbook of Ocular Pharmacology. Lippincott-Raven, 1997.
 
 
PREVIOUS
 
 
Page: 1 | 2 | 3 | 4 | 5
  
 

10.1036/1535-8860.ch3

Customer Privacy Policy
Copyright ©2002-2003 The McGraw-Hill Companies. All rights reserved.
Any use is subject to the Terms of Use and Notice. Additional credits and copyright information. For further information about this site contact tech_support@accessmedicine.com.
Last modified: October 30, 2002 .
McGraw-HillEducation
The McGraw-Hill Companies
Top